The CEO (Eddy Tsai) and CFO (Christopher Lee) articulate a clear platform vision that integrates edge hardware, a real‑world smell dataset, and a smell language model, and have secured notable partnerships (ASE, Topco, Trusval) plus early orders in semiconductors and pilots in hospital settings.
That said, the record so far is heavy on announcements and light on recognized revenue, and financing choices have been dilutive and related‑party‑dependent. We see focus and persistence, but not yet an owner‑operator track record of capital discipline and compounding cash flows that we prize in this framework.







